CD163 and macrophage activation syndrome: With the processing of infection, the results observed at day 1 switched to a strong elevation of surface CD163 by the virulent strains and, subsequently, increased levels of sCD163, which has been recognized as an evident biomarker of sepsis, comorbidity, mortality and macrophage activation syndrome [32] in serum (days 3–4) [14].